Addex Therapeutics Ltd. (ADXN)
3.75
-0.30
(-7.41%)
USD |
NASDAQ |
Aug 25, 16:00
3.76
+0.01
(+0.27%)
After-Hours: 19:59
Addex Therapeutics Total Assets (Quarterly) : 5.920M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 5.920M |
| December 31, 2025 | 8.027M |
| September 30, 2025 | 9.205M |
| June 30, 2025 | 10.68M |
| March 31, 2025 | 10.71M |
| December 31, 2024 | 11.78M |
| September 30, 2024 | 14.42M |
| June 30, 2024 | 15.24M |
| March 31, 2024 | 3.701M |
| December 31, 2023 | 5.514M |
| September 30, 2023 | 6.709M |
| June 30, 2023 | 10.04M |
| March 31, 2023 | 7.980M |
| December 31, 2022 | 8.948M |
| September 30, 2022 | 12.44M |
| June 30, 2022 | 11.89M |
| March 31, 2022 | 19.21M |
| December 31, 2021 | 24.72M |
| September 30, 2021 | 19.36M |
| June 30, 2021 | 23.25M |
| March 31, 2021 | 28.56M |
| December 31, 2020 | 22.76M |
| September 30, 2020 | 21.38M |
| June 30, 2020 | 24.43M |
| March 31, 2020 | 29.84M |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Novartis AG | 122.03B |
| Roche Holding AG | -- |
| Oculis Holding AG | 310.34M |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.832M |
| Shareholders Equity (Quarterly) | 4.087M |
| Debt to Equity Ratio | 0.0311 |
| Current Ratio | 0.9715 |
| Net Debt Paydown Yield | -0.26% |